Ignite Creation Date:
2024-05-06 @ 4:10 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04896541
Status:
COMPLETED
Last Update Posted:
2022-06-27
First Post:
2021-02-26
Brief Title:
Phase I Double-blind Placebo-controlled Study of AZD7442
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| COVID-19 |
Keywords: